ATE492629T1 - Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur - Google Patents

Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur

Info

Publication number
ATE492629T1
ATE492629T1 AT07718278T AT07718278T ATE492629T1 AT E492629 T1 ATE492629 T1 AT E492629T1 AT 07718278 T AT07718278 T AT 07718278T AT 07718278 T AT07718278 T AT 07718278T AT E492629 T1 ATE492629 T1 AT E492629T1
Authority
AT
Austria
Prior art keywords
pancreas
cells
cell culture
cell proliferation
improved
Prior art date
Application number
AT07718278T
Other languages
English (en)
Inventor
Monica Florio
Aleksandar Francki
Wen-Ghih Tsang
Original Assignee
Reneuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Inc filed Critical Reneuron Inc
Application granted granted Critical
Publication of ATE492629T1 publication Critical patent/ATE492629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/32—Polylysine, polyornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
AT07718278T 2006-01-20 2007-01-18 Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur ATE492629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76044506P 2006-01-20 2006-01-20
PCT/US2007/001555 WO2007084730A2 (en) 2006-01-20 2007-01-18 Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture

Publications (1)

Publication Number Publication Date
ATE492629T1 true ATE492629T1 (de) 2011-01-15

Family

ID=38288290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07718278T ATE492629T1 (de) 2006-01-20 2007-01-18 Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur

Country Status (8)

Country Link
US (1) US9745554B2 (de)
EP (1) EP1994140B1 (de)
JP (1) JP5459823B2 (de)
AT (1) ATE492629T1 (de)
AU (1) AU2007207434B2 (de)
CA (1) CA2637843C (de)
DE (1) DE602007011409D1 (de)
WO (1) WO2007084730A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2923160B1 (fr) 2007-11-02 2013-07-26 Pasteur Institut Composes destines a prevenir ou traiter une infection virale.
CN103827303B (zh) 2011-09-26 2021-10-22 普瑞阿那利提克斯有限公司 细胞外核酸的稳定化和分离
US11021733B2 (en) 2011-09-26 2021-06-01 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
US20140227688A1 (en) 2011-09-26 2014-08-14 Qiagen Gmbh Stabilisation and isolation of extracellular nucleic acids
CN102589955A (zh) * 2012-01-15 2012-07-18 中国人民解放军第四军医大学 一种检测体液细胞中结核杆菌的染色试剂盒
EP2900834B1 (de) 2012-09-25 2016-11-09 Qiagen GmbH Stabilisierung von biologischen proben
WO2014117080A1 (en) * 2013-01-25 2014-07-31 Wake Forest University Health Sciences Compositions and methods for maintaining and improving pancreatic islet cell function and stability
EP2976424B1 (de) 2013-03-18 2018-10-03 Qiagen GmbH Stabilisierung von biologischen proben
WO2014146780A1 (en) 2013-03-18 2014-09-25 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
KR102580225B1 (ko) 2013-06-11 2023-09-20 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 SC-β 세포 및 조성물 그리고 그 생성 방법
SG11201700874SA (en) 2014-08-04 2017-03-30 Takeda Pharmaceuticals Co Method for proliferation of pancreatic progenitor cells
ES2985135T3 (es) 2014-12-18 2024-11-04 Harvard College Procedimientos para generar células ß derivadas de células madre y usos de las mismas
WO2016100898A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof
WO2016100930A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Methods for generating stem cell-derived b cells and methods of use thereof
EP3377645B1 (de) 2015-11-20 2023-10-04 Qiagen GmbH Verfahren zur herstellung sterilisierter zusammensetzungen zur stabilisierung von extrazellulären nukleinsäuren
CN118497104A (zh) 2017-11-15 2024-08-16 沃泰克斯药物股份有限公司 胰岛细胞制备性组合物和使用方法
EP3833365A4 (de) 2018-08-10 2022-05-11 Vertex Pharmaceuticals Incorporated Aus stammzellen gewonnene inseldifferenzierung
CN115551536A (zh) * 2020-03-30 2022-12-30 约翰斯·霍普金斯大学 用于增强损伤修复以及治疗细菌和病毒感染的胱天蛋白酶抑制剂
CN116829697A (zh) * 2021-02-09 2023-09-29 千纸鹤治疗公司 促熟剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562620B2 (en) * 1997-09-19 2003-05-13 Mcgill University Medium to promote islet cell survival
WO2005086860A2 (en) * 2004-03-09 2005-09-22 Gang Xu Methods for generating insulin-producing cells
US7807459B2 (en) * 2005-09-27 2010-10-05 Reneuron, Inc. EphA4-positive human adult pancreatic endocrine progenitor cells
US7875451B2 (en) * 2006-01-19 2011-01-25 The University Of Washington Formulation to improve survival of transplanted cells

Also Published As

Publication number Publication date
CA2637843C (en) 2014-12-30
JP5459823B2 (ja) 2014-04-02
EP1994140B1 (de) 2010-12-22
EP1994140A4 (de) 2009-04-08
US9745554B2 (en) 2017-08-29
EP1994140A2 (de) 2008-11-26
AU2007207434B2 (en) 2012-04-05
AU2007207434A1 (en) 2007-07-26
DE602007011409D1 (de) 2011-02-03
JP2009523449A (ja) 2009-06-25
CA2637843A1 (en) 2007-07-26
WO2007084730A3 (en) 2007-12-27
US20100311166A1 (en) 2010-12-09
WO2007084730A2 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
DE602007011409D1 (de) Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur
IN2014DN10053A (de)
GB2451523B (en) Pluripotent cells from rat and other species
MX349178B (es) Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
MX2015010841A (es) Modificacion genetica de ratas.
GB2454386A (en) Method for stem cell culture and cells derived therefrom
UY31222A1 (es) Modificación enzimática del aceite
GB2452456A (en) Cell growth medium
ATE500327T1 (de) Verfahren und zusammensetzungen für ethanolproduzierende cyanobakterien
MX2008011838A (es) Propagacion de celulas primarias.
WO2010033906A3 (en) Efficient induction of pluripotent stem cells using small molecule compounds
EP4585589A3 (de) Stammzellenkulturen
MX2009007999A (es) Hidrolisis de almidon utilizando fitasa con una alfa amilasa.
MY157524A (en) Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a muc1 or muc1* ligand
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
MX2011011402A (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
MX2010000348A (es) Cultivo de celulas madre pluripotentes individuales.
NZ709124A (en) Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
ATE477714T1 (de) Verfahren zur behandlung von pflanzlichem material mit einem enzym
GB2477698A (en) Methods for conducting cellular assays
MX2009009835A (es) Composiciones de limpieza las cuales comprenden transglucosidasa.
BR112017016077A2 (pt) ?composição e método para uso no aumento da eficácia do enxerto de células-tronco hematopoiéticas após transplante?
WO2012162518A3 (en) Method for the remediation of water generated from natural resource production operations
WO2006113881A3 (en) Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
ATE480615T1 (de) Verfahren zur proliferation von stammzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties